Phase-I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma. - Vose,J.M.; Bierman,P.J.; Enke,C.; Hankins,J.; Bociek,G.; Lynch,J.C. (J Clin Oncol, 2005)